• Non ci sono risultati.

Scarica il programma preliminare in formato PDF

N/A
N/A
Protected

Academic year: 2022

Condividi "Scarica il programma preliminare in formato PDF"

Copied!
5
0
0

Testo completo

(1)

VI EUROPEAN CONFERENCE ON SURVIVORS AND CHRONIC CANCER PATIENTS 23-24 SEPTEMBER 2016

SIRACUSA

23 SETTEMBRE 2016

SATELLYTE SYMPOSIUM Free Access

9.00- 10,30 Session I: What is cancer

10.30 – 12.30 Prevention and support to therapies. Which nutrition?

10.30 The nutritional aspect during treatment within Medical Oncology Unit of Siracusa P. Tralongo

10.50 Nutritional Research in Oncology: from prospective observational studies to diet trials for population health

P. Pasanisi

11.10 Lifestyles aimed at stomach and bowel cancer prevention R. Cannizzaro

11.30 The correct information on nutritional styles. Targeted prevention in cancer patients V. Grado

11.50 The Mediterranean diet: the new discovery of our traditions F. Romano 12.10 Lifestyle and nutrition. An aspects rehabilitation of the cancer patients.

M. Bongiovanni 12.30 End of Symposium

(2)

23 SETTEMBRE 2016

14.00 Participant registration 15.15 Welcome greetings

Session I

The patients and their needs

Coordinators: G. Numico – P. Tralongo

15:30 Key note lecture: Season of survivorship A. Surbone 16.00 What to research and for who? C. Johansen 16.20 The driver and the model Mary McCabe

16.40 Bone health D. Santini

17.00 Patients : physical and psychological specific needs Anna Costato 17:20 Pause

17.50 Return to work: insurance issues Kathi Apostolidis

18.10 The research Jan Geissler

18.30 Rehabilitation needs JK Silver

18.50 The relevance of training and education Giacomo Pignataro 19.10 End of scientific session

24 SETTEMBRE 2016 Session II

PHYSICAL E PSYCOLOGICAL NEEDS

BREAST

08:30 Current treatment and new approach P.F. Conte

08:45 Most frequent toxicity and new side effects of novel drugs and/or treatments F. Puglisi

09:00 Questions: Caruso

PROSTATE

09:15 Current treatment and new approach S. Bracarda

09:30 Most frequent toxicity and new side effects of novel drugs and/or treatments M. Caffo

09:45 Questions: A. Butera

(3)

10:00 Pause

NEOPLASM GERM CELL

10:30 Current treatment and new approach U. De Giorgi

10:45 Most frequent toxicity and new side effects of novel drugs and/or treatments G. Pelosi

11:00 Questions: G.L. Banna

THYROID

11:15 Current treatment and new approach R. Elisei

11:30 Most frequent toxicity and new side effects of novel drugs and/or treatments D. Giuffrida

11:45 Questions:

CERVIX

12:00 Current treatment and new approach N. Colombo

12:15 Most frequent toxicity and new side effects of novel drugs and/or treatments D. Lorusso

12:30 Questions

12:45 Snack Lunch KIDNEY

14:00 Current treatment and new approach G. Procopio

14:15 Most frequent toxicity and new side effects of novel drugs and/or treatments M. Milella

14:30 Questions

COLON

14:45 Current treatment and new approach S. Siena

15:00 Most frequent toxicity and new side effects of novel drugs and/or treatments R. Bordonaro

15:15 Questions: M. Beretta

(4)

MELANOMA

15:30 Current treatment and new approach P. Ascierto

15:45 Most frequent toxicity and new side effects of novel drugs and/or treatments F. Ferraù

16:00 Questions:

LYMPHOMAS

16:15 Current treatment and new approach A. Santoro

16:30 Most frequent toxicity and new side effects of novel drugs and/or treatments F. Di Raimondo

17:00 Questions: M. Spina 17.15 General debate

17:45 Final greeting and end of the conference 18:00 CME Test

18.30 Closing addresses

(5)

GENERAL INFORMATION

DIRECTORS OF THE CONFERENCE

Paolo Tralongo Director, Medical Oncology Unit., Umberto I Hospital, Siracusa – Italy

SCIENTIFIC COMMITTEE

S. Bordonaro - A Di Mari - M. Iacono - E. Lanteri - S. Roccaro - F. Romano

CONFERENCE VENUE Sala Ferruzza – Romano Plemmirio

Siracusa - Italy

ABSTRACT (Deadline for submission 31st May)

We welcome abstracts that report findings from original research; studies based on any methodological approach, whether quantitative and qualitative results, will be considered. Abstracts may focus on the cured and longterm cancer patients. Specifically, abstracts should address topics that are of particular relevance to the practice of clinical oncologists and/or primary care.

Abstracts should be structured, with 300 words or less, highlighting background, methods, results and conclusions.

Please submit your abstract as a Word Document; other formats will not be accepted.

Abstracts will be selected based on their quality, and invited for presentation as a poster or oral format.

More than one abstract may be submitted.

CME ACCREDITATION INFORMATION

The Organizing Secretariat will apply to the Italian Ministry of Health for Continuing Medical Education (CME) accreditation.

Provider: CFSS (Centro Formazione Sanitaria Sicilia) – ID 702

The CME credits will be awarded only after the attendance at 100% at the scientific sessions.

REGISTRATION (Deadline: 1st September 2016)

Specialist € 150,00

N. 90 Registration Avaible

THE REGISTRATION INCLUDES

- Partecipation to the Conference - Certificate of attendence - Conference kit

- Snack break

- CME Certificate (after passing test)

ORGANIZING SECRETARIAT

PRESS OFFICE

Tel: 0039. 0931.1960524 [email protected]

FOR MORE INFORMATION www.oncologicicronici.it and www.borgigroup.com

Riferimenti

Documenti correlati

Pasquale Lorenzo Moja - OMS – Organizzazione Mondiale della Sanità Roberto Negrini, Direttore U.O.C. di Bologna Lorenzo Noto, Responsabile Sistemi Informativi - A.U.S.L. Valle

Inoltre, la cura globale dei pazienti con carcinoma testa-collo recidivati o me- tastatici richiede la valutazione di diversi aspetti correlati sia alla malattia stessa sia

9.00 Il Follow-up dei pazienti oncologici - Gianmauro Numico (AO Alessandria) 9.20 Il Follow-up dei pazienti ematologici – Stefano Luminari (IRCCS ASMN, Reggio E) 9.40

[r]

è per noi un grande onore invitarvi al XXVI Congresso Nazionale della Società Italiana di Urologia Oncologica (SIUrO), che si terrà al Palazzo dei Congressi di Firenze dal 9

Reggio Emilia , Arcispedale Santa Maria Nuova, Padiglione Rocca

12.30 THBT hypo-fractionated irradiation and partial breast irradiation are recommended after breast conserving surgery. Domenico

In particolar modo, per ciascuna delle principali patologie uro-oncologiche trattate, Prostata, Vescica e Rene, verranno discussi e definiti i requisiti standard per